Hanks Lab

@DukeCancer lab focused on tumor immune evasion and dendritic cell biology, developing novel approaches to help our immune system target cancer

[ASCO @ASCO]

Stay on top of the rapidly developing field of immunotherapy as it relates to oncology with #ASCOU https://t.co/poQ6v2hfNd

[Cancer Research Institute @CancerResearch]

Learn about how #immunotherapy empowers our immune system to attack & destroy #cancer: https://t.co/PYHExzEx9P

[Cancer Research Institute @CancerResearch]

.@CNN covers immunotherapy's history, progress and challenges: https://t.co/MNCt05UadJ

[Hanks Lab @hanks_lab]

Key article for an immunology library: Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells https://t.co/7Yyoh2A9qT

[Hanks Lab @hanks_lab]

One of our lab's research goals is to help determine why! https://t.co/u994Bq0e2c

[AACR @AACR]

On the blog: Why does #immunotherapy not benefit everyone long-term? https://t.co/wtE9xyRQ8L

[Cancer Research Institute @CancerResearch]

.@nytimes' cancer immunotherapy cover story touches on how the treatment works, potential side effects, cost & more https://t.co/AWZB4BQkwj

[JAMA Oncology @JAMAOnc]

Ability of #genomics to identify #tumors most likely to respond to immune checkpoint inhibitors https://t.co/JasexJwvih

[Society for Immunotherapy of Cancer @sitcancer]

Working on new #CancerImmunotherapy agent? Apply for chance to present at #SITC2016. Deadline Aug. 8. bit.yl/2016sitc

[Hanks Lab @hanks_lab]

This month's journal club: Melanoma can resist T cell killing via inflam. induced reversible dedifferentiation https://t.co/HMB3FstfSx

[Hanks Lab @hanks_lab]

The Hanks Lab @DukeCancer is officially on twitter! Finding new ways to help our immune system tackle cancer.